QC Analyst at pharmaceutical multinational

Définir une nouvelle alerte d’emplois
16392en
  1. Contract
  2. English
  3. Associate
  4. Research & Development
  5. Switzerland
  6. Healthcare & Life Sciences
On behalf of our client, a leading international biotechnology company based in Visp, Swisslinx is looking for a QC Analyst. In this role, you will ensure pharmaceutical quality through lab analyses, method validation, and documentation in a GMP environment, collaborating as a reliable and communicative team member.

Contract type - Contract
Start Date - January
Location - Visp
Workload - 100%
Duration - 6 months

Your mission:
• Perform and release in-process controls (HPLC, CE, icIEF, etc.) in compliance with cGMP guidelines
• Support method validation activities
• Maintenance of existing infrastructures
• Carry out routine final analyses and stability samples for time-critical samples
• Test and assess random product samples to ensure minimum pre-defined standards are met.
• Aggregate test data and documents results of testing.
Your background:
• Fluent in English mandatory, German is a plus
• You have completed training and ideally already have experience in analytical work in pharmaceutical industry
• You are a team player, responsible, resilient and communicative
• You have a high level of quality awareness and an efficient way of working
• You have good comprehension skills, are independent and work reliably
• You have a safe handling of potentially hazardous substances
• You are confident in using a PC and standard software
• experienced with HPLC technique
• hands-on lab experience in GMP environment
What's on offer
• A 6 month contract.
• A great opportunity to develop your career at a leading international biotechnology company.
• A competitive salary.

If this sounds like you, don’t hesitate to apply here or reach out directly to Hugo Palejowski, Recruiter: hugo.palejowski@swisslinx.com.

Comment la technologie impacte-t-elle la santé et les sciences de la vie ?

EN SAVOIR PLUS

Faire des affaires à Zurich : les tendances à surveiller

EN SAVOIR PLUS